
Results
38
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
38 companies
Johnson & Johnson
Market Cap: US$506.0b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$211.58
7D
4.8%
1Y
44.3%
Novartis
Market Cap: CHF 202.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 105.50
7D
-1.5%
1Y
20.2%
Merck
Market Cap: US$245.7b
Operates as a healthcare company worldwide.
MRK
US$100.30
7D
0.6%
1Y
-1.7%
Exelixis
Market Cap: US$11.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$40.88
7D
-7.8%
1Y
16.7%
Orion Oyj
Market Cap: €8.4b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€60.05
7D
-1.3%
1Y
43.5%
SK Biopharmaceuticals
Market Cap: ₩10.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩133,200.00
7D
-0.6%
1Y
25.8%
Abbott India
Market Cap: ₹594.1b
Operates as a pharmaceutical company in India.
500488
₹27,959.55
7D
-3.2%
1Y
-2.4%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥44.6b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥99.14
7D
3.0%
1Y
54.0%
Zealand Pharma
Market Cap: DKK 34.6b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 492.80
7D
-3.0%
1Y
-36.9%
Xiamen Amoytop Biotech
Market Cap: CN¥34.3b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥84.01
7D
3.0%
1Y
23.9%
ADMA Biologics
Market Cap: US$4.9b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$19.78
7D
-0.4%
1Y
6.4%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥30.9b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥46.17
7D
-0.7%
1Y
43.1%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥17.7b
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
300573
CN¥71.66
7D
-1.8%
1Y
19.2%
HUTCHMED (China)
Market Cap: UK£1.8b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.04
7D
-4.2%
1Y
-17.4%
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$19.01
7D
-3.7%
1Y
42.7%
Philogen
Market Cap: €938.2m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.
PHIL
€23.30
7D
-0.4%
1Y
25.3%
Sanofi India
Market Cap: ₹97.7b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹4,241.15
7D
-2.2%
1Y
-31.7%
Procter & Gamble Health
Market Cap: ₹92.6b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹5,579.05
7D
-2.3%
1Y
-1.7%
CorMedix
Market Cap: US$925.0m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$11.49
7D
8.8%
1Y
37.1%
Sunmax Biotechnology
Market Cap: NT$21.3b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$391.00
7D
-1.8%
1Y
41.9%
SIGA Technologies
Market Cap: US$462.6m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.46
7D
4.2%
1Y
4.5%
Ever Supreme Bio Technology
Market Cap: NT$14.4b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$164.50
7D
-2.7%
1Y
4.3%
GlaxoSmithKline Pakistan
Market Cap: PK₨124.4b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨390.50
7D
-0.9%
1Y
-7.0%
RPG Life Sciences
Market Cap: ₹38.3b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,316.40
7D
5.2%
1Y
2.0%
PharmaEngine
Market Cap: NT$10.1b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$70.40
7D
-3.0%
1Y
-20.7%
Abeona Therapeutics
Market Cap: US$299.1m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.36
7D
10.1%
1Y
-9.0%
Puma Biotechnology
Market Cap: US$288.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.86
7D
10.6%
1Y
103.5%
Hoechst Pakistan
Market Cap: PK₨45.4b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,711.61
7D
8.7%
1Y
67.4%
Cantargia
Market Cap: SEK 1.1b
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 4.41
7D
15.9%
1Y
144.7%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft36.8b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,660.00
7D
0.8%
1Y
9.9%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م4.1b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م814.05
7D
0.1%
1Y
156.1%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م4.0b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م269.44
7D
-1.6%
1Y
128.2%
2invest
Market Cap: €64.5m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally.
2INV
€11.70
7D
0%
1Y
0%
BioStem Technologies
Market Cap: US$71.5m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$4.14
7D
4.7%
1Y
-75.9%
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫1.7t
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫177,000.00
7D
-0.1%
1Y
45.2%
Arab Drug
Market Cap: ج.م2.7b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م225.50
7D
-0.4%
1Y
249.6%